The global nucleic acid isolation and purification market size was estimated at USD 5.38 billion in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 9.24% from 2024 to 2030. The market expansion is fueled by several factors, such as the rise in adoption of sequencing platforms for clinical diagnostics, growth in genomics & enzymology-based research, and increase in investments in R&D. The potential of molecular biology and advancement in precision medicine are further augmenting market growth. Increasing efforts of market participants to strengthen the manufacturing capacity is facilitating market expansion. For instance, in January 2023, Agilent Technologies announced an investment of USD 725 million to increase the manufacturing capacity of therapeutic nucleic acids.
The incidence of genetic disorders, cancer, and infectious diseases has been growing globally for the past few years. Disorders such as thalassemia, sickle cell anemia, and cystic fibrosis are caused by genetic aberrations in an individual’s DNA. Studying nucleic acids helps gain insights into these diseases. The race for developing cost-effective, point-of-contact testing kits and efficient laboratory procedures for detecting COVID-19 infection has driven a new scope of diagnostic innovation. An increase in the adoption of PCR for SARS-CoV-2 detection by a broad range of commercial laboratories drives the market, as nucleic acid isolation & purification is a significant step in the PCR workflow.
The biotechnology industry is also marked with advancements and innovations. Diagnostic tests have become more cost-effective and easier to use. The companies are investing to advance the DNA isolation process. For instance, in August 2023, Gold Standard Diagnostics (GSD) announced the launch of iMAGo PREDigest. This kit completes GSD's whole DNA isolation portfolio, delivering an automated (iMAGo Food) and manual (GeneSpin) solution with respective pre- and post-treatment offerings for difficult matrices. Automated and advanced instruments have entered the market with faster, more consistent, and cleaner processes. For instance, Thermo Fisher Scientific offers an Automated Nucleic Acid Extraction Workstation that uses revolutionary magnetic separation technology.
The nucleic acid isolation and purification market growth stage is high and the pace is accelerating. The NAIP market is characterized by a moderate to high degree of innovation due to rapid advancements and innovations in the biotechnology industry. It utilizes molecular detection platforms, robotic liquid handling technology, droplet digital PCR, NGS, and genome-wide sequencing, among others in effective extraction and purification of nucleic acid.
The nucleic acid isolation & purification market is further characterized by a moderate level of merger and acquisition (M&A) activity by the leading players. This is due to several factors, including the desire to gain access to new nucleic acid isolation & purification facilities, increase their capabilities, expand product portfolios, and improve competencies.
The NAIP market is also subject to substantial regulatory scrutiny. Manufacturers and suppliers of nucleic acid isolation and purification kits and instruments must comply with various regulations, such as those related to genomics, forensics, molecular diagnostics, and genetic engineering.
The NAIP market has a moderate level of product/service expansion. This expansion involves introducing new types of extraction and purification kits, improving extraction procedures, and providing additional services to support customers.The product expansion enables companies to expand their nucleic acid isolation and purification portfolio.
Regional expansion is a significant factor with moderate to high growth in the NAIP market. Since several end-user industries drive demand for DNA/RNA extraction and purification, the market players are investing in regional expansion to increase manufacturing capacity. Furthermore, regional expansion enables players to capture the untapped customer base, thereby contributing to the growth of the oligonucleotide synthesis market.
The kits & reagents segment dominated the market with the highest share of 72.05% in 2023. The NAIP market comprises a wide range of DNA and RNA isolation/extraction and purification kits for preparing samples and libraries. The players are focusing on new product launches to cater to specific needs. For instance, in June 2023, Bionano Genomics, Inc. announced the Ionic Purification System, a kit for nucleic acid extraction from tumor tissue and formalin-fixed paraffin-embedded (FFPE).
The instruments segment is anticipated to grow considerably at a CAGR of 11.17% from 2024 to 2030. This high growth is attributed to technological advancements in instruments, strong end-user demand, and increased demand for automated NAIP instruments. Also, recent product launches from manufacturers are another factor supporting segment expansion. For instance, in December 2023, Omega Bio-tek announced the launch of MagBinder Fit24, a lab hardware isolating DNA or RNA from diverse sample types.
The DNA isolation and purification segment registered the highest market share of 59.3 % in 2023. DNA extraction and purification are used in a variety of molecular biology applications. The basic criteria that must be met by any method of DNA isolation and purification from any sample are efficient extraction and isolation, enough DNA for downstream steps, contaminant removal, and quality & purity of DNA. Hence, the market players are investing in DNA isolation & purification solutions. For instance, in May 2023, One BioMed launched X8 HMW DNA Cartridge Kits. It specializes in the automated isolation of high molecular weight DNA for genome assembly and long-read sequencing.
The RNA isolation & purification segment is anticipated to witness a steady CAGR from 2024 to 2030. Purified mRNA is essential for the construction of a cDNA library. These libraries have various applications in the healthcare sector, such as in gene expression profiling, sequencing, and clinical diagnostics. Availability of a broad range of kits in the market for extracting and processing viral, bacterial, and total RNA, among other types. Hence, companies are launching several solutions for RNA isolation & purification. For instance, in November 2023, BioEcho Life Sciences announced the launch of EchoLUTION FFPE RNA Kit for simplified RNA extraction from FFPE samples.
The diagnostic segment led with the highest market share of 32.7 in 2023. This can be attributed to the rising application of DNA and RNA isolation for identifying pathogens in routine sample processing. For instance, PCR techniques are widely adopted for rapidly detecting microorganisms, which was previously impossible with traditional microbiological detection methods. Hence, companies are launching new diagnostic solutions. For instance, in November 2023, QIAGEN launched RNeasy PowerMax and TissueLyser III Soil Pro Kit. The kit isolates pure RNA from PCR inhibitors-rich soil samples. Thus, the launch of new products for diagnosing emerging infections further contributes to segment growth.
The drug discovery & development segment is projected to witness a lucrative CAGR over the forecast period. This growth can be primarily attributed to robust investments in pharmaceutical and biotechnology companies to develop novel drugs. Nucleic acid purification methods are largely employed in drug discovery, target identification, and testing.
The magnetic beads segment dominated the market with the highest share in 2023. The magnetic bead method is an advanced and highly sophisticated DNA/RNA extraction procedure where small magnetic beads coated with DNA-binding oxides or antibodies are used. Since they show affinity toward DNA molecules, this method helps extract the purest possible form of DNA/RNA and exclude other unwanted materials from the sample mixture. Hence, companies use this method in nucleic acid isolation & purification solutions. For instance, in November 2023, CleanNA launched CE-IVD marked ‘Clean Cell Free DNA Kit’ to isolate cell-free DNA from human plasma with its magnetic bead technology. This is used automation and use in diagnostic procedures.
The column-based segment is expected to register a significant CAGR from 2024 to 2030. Silica columns are mainly preferred for getting higher-quality nucleic acids in less time. Moreover, these techniques can be incorporated in spin columns with various benefits such as fast process, higher yield, cost-effectivity, and compatibility with automated instruments. Therefore, these methods are widely adopted in DNA extraction processes.
The hospitals and diagnostics centers segment held the largest revenue share of 32.3% in 2023 as the use of nucleic acids in hospitals and diagnostic centers has increased due to their wide range of applications in healthcare segments, such as genetic fingerprinting, prenatal testing, and liquid biopsies. DNA and RNA isolation and purification techniques are considered efficient tools for diagnosing certain genetic diseases such as sickle cell anemia, hemophilia A, fragile X syndrome, cystic fibrosis, Down’s syndrome, and Tay-Sachs disease, to name a few. Thus, the availability of such technologies at low prices is projected to drive their adoption rate in diagnostic centers and hospitals.
The pharmaceutical and biotechnology companies segment is expected to register the fastest CAGR from 2024 to 2030. The rising adoption of advanced technologies by companies to develop various novel therapies is projected to drive segment growth. For instance, in 2023, the FDA's Center for Drug Evaluation and Research (CDER) approved 55 new drugs. As nucleic acid purification and isolation is a critical step in drug discovery and development, higher demand for DNA extraction kits and instruments in pharma and biotech companies is anticipated to drive segment growth.
North America held the largest revenue share of 40.25% in 2023. Presence of many market players in the region and their initiatives are projected to drive the regional growth. In addition, leveraged government support, a favorable regulatory framework, and consistent R&D efforts are expected to drive the market during the forecast period. Moreover, the local presence of several major players in the U.S., such as Thermo Fisher Scientific, Inc. and Agilent Technologies, also drives technological progression in the market. These players are undertaking significant efforts to develop automatic nucleic acid purification systems for downstream applications, including next-generation sequencing and real-time PCR.
Asia Pacific is expected to register the fastest growth throughout the forecast period. Ongoing developments, growing patient population, private-public collaborations, and supportive government initiatives have offered immense opportunities for the growth of the regional market. Various leading companies in China, India, and Japan, among other countries, operate in the region and offer a broad range of kits for isolating and purifying genomic and plasmid DNA from various samples, including serum, blood, cells, tissue, forensic, and plant samples. More such efforts are expected to contribute toward the regional growth.
Many companies are aiming for product approvals and launches to strengthen their market position. Moreover, they are undertaking regional expansions and collaborations to increase the manufacturing capacity and sharing of technologies to develop efficient nucleic acid isolation and purification solutions.
The following are the leading companies in the nucleic acid isolation and purification market. These companies collectively hold the largest market share and dictate industry trends. Financials, strategy maps & products of these nucleic acid isolation and purification companies are analyzed to map the supply network.
In December 2023, Thermo Fisher Scientific Inc. launched an automatic nucleic acid purification instrument, Thermo Scientific KingFisher Apex Dx, and Applied Biosystems MagMAX Dx Pathogen/Viral NA Isolation Kit to isolate and purify bacterial and viral pathogens from biological samples.
In November 2023, LGC Biosearch Technologies announced the acquisition of PolyDesign, a manufacturer of solid support embedded frits used for DNA/RNA oligonucleotide synthesis and purification. The proprietary frit technology aligns with LGC’s Nucleic Acid Chemistry product catalog.
In August 2023, CD Bioparticles launched a new line of DNA Extraction and Purification Kits. The kits are designed for reliable and rapid isolation of DNA, including plasmid DNA, genomic DNA, cell-free DNA (cfDNA), mitochondrial DNA, tissue DNA, and PCR products.
In July 2023, INOVIQ Limited and Promega Corporation announced a global collaborative marketing agreement to market Promega Nucleic Acid purification systems and EXO-NET exosome capture technology.
In February 2023, Agilent Technologies, Inc. announced the selection of Fluor Corporation's Advanced Technologies & Life Sciences business to expand its oligonucleotide therapeutics manufacturing unit in Colorado. This facility available for the synthesis, lyophilization, and purification of custom nucleic acids therapeutics.
In January 2023, QIAGEN announced the launch of the EZ2 Connect MDx platform for automated sample processing in diagnostic labs to enable the purification of DNA and RNA from 24 samples in parallel in under 30 minutes.
Report Attribute |
Details |
Market size value in 2024 |
USD 5.75 billion |
Revenue forecast in 2030 |
USD 9.77 billion |
Growth rate |
CAGR of 9.24% from 2024 to 2030 |
Base year of estimation |
2023 |
Actual data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Report updated |
January 2024 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, type, application, method, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; Germany; UK; France; Spain; Italy; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Argentina; Mexico; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
QIAGEN; Thermo Fisher Scientific, Inc.; Illumina, Inc.; Danaher; F. Hoffmann-La Roche Ltd; Merck KGaA; Agilent Technologies; Bio-Rad Laboratories, Inc.; Takara Bio Inc.; Promega Corporation |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global nucleic acid isolation and purification market report based on product, type, application, method, end-use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Kits & Reagents
Instruments
Manual
Automatic
Type Outlook (Revenue, USD Million, 2018 - 2030)
DNA Isolation & Purification
Genomic DNA Isolation & Purification
Plasmid DNA Isolation & Purification
Viral DNA Isolation & Purification
Other
RNA Isolation & Purification
miRNA Isolation & Purification
mRNA Isolation & Purification
Total RNA Isolation & Purification
Other
Application Outlook (Revenue, USD Million, 2018 - 2030)
Precision Medicine
Diagnostics
Drug Discovery & Development
Agriculture and Animal Research
Other Applications
Method Outlook (Revenue, USD Million, 2018 -2030)
Column-based
Magnetic Beads
Reagent-based
Others
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Academic Research Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Hospitals and Diagnostic Centers
Other End-use
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
UK
France
Spain
Italy
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
b. The global nucleic acid isolation and purification market size was estimated at USD 5.38 billion in 2023 and is expected to reach USD 5.75 billion in 2024.
b. The global nucleic acid isolation and purification market is expected to witness a compound annual growth rate of 9.24% from 2024 to 2030 to reach USD 9.77 billion by 2030.
b. Kits and reagents accounted for the largest share in 2023 due to the wide availability of robust kits for isolation of DNA or RNA from the given sample contributed to the dominance of this segment.
b. Some key players operating in the nucleic acid isolation and purification market include QIAGEN; Illumina, Inc.; Danaher; F. Hoffmann-La Roche Ltd.; Merck KGaA; Thermo Fisher Scientific, Inc.; Agilent Technologies; Bio-Rad Laboratories, Inc.; GE Healthcare; Promega Corporation; and Norgen Biotek Corp.
b. Expanding pipeline for RNA therapeutics, plummeting sequencing cost, and growing popularity of nucleic acid-based diagnostics are some key driving factors of the nucleic acid isolation & purification market.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Type
1.2.3. Application
1.2.4. Method
1.2.5. End-use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Nucleic Acid Isolation And Purification Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing incidence of cancer, genetic disorders, and infectious diseases
3.2.1.2. Increase in public-private funding for biotechnology and life science research
3.2.1.3. Advancements in automation
3.2.1.4. Growth in NGS technologies
3.2.1.5. Growing demand for genetically modified crops and organisms
3.2.2. Market restraint analysis
3.2.2.1. Expensive instruments and consequent low penetration in emerging countries
3.2.2.2. Challenges related to the use of big data and bioinformatics
3.3. Industry Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Analysis
Chapter 4. Product Business Analysis
4.1. Nucleic Acid Isolation and Purification Market: Product Movement Analysis
4.2. Kits & Reagents
4.2.1. Kits & reagents market estimates and forecasts, 2018 - 2030 (USD Million)
4.3. Instruments
4.3.1. Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.2. Manual
4.3.2.1. Manual market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.3. Automatic
4.3.3.1. Automatic market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Type Business Analysis
5.1. Nucleic Acid Isolation and Purification Market: Type Movement Analysis
5.2. DNA Isolation & Purification
5.2.1. DNA isolation & purification market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.2. Genomic DNA Isolation & Purification
5.2.2.1. Genomic DNA isolation & purification market estimates and forecasts 2018 - 2030 (USD Million)
5.2.3. Plasmid DNA Isolation & Purification
5.2.3.1. Plasmid DNA isolation & purification market estimates and forecasts 2018 - 2030 (USD Million)
5.2.4. Viral DNA Isolation & Purification
5.2.4.1. Viral DNA isolation & purification market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.5. Other
5.2.5.1. Other market estimates and forecasts, 2018 - 2030 (USD Million)
5.3. RNA Isolation & Purification
5.3.1. RNA isolation & purification market estimates and forecasts, 2018 - 2030 (USD Million)
5.3.2. miRNA Isolation & Purification
5.3.2.1. miRNA isolation & purification market estimates and forecasts, 2018 - 2030 (USD Million)
5.3.3. mRNA Isolation & Purification
5.3.3.1. mRNA isolation & purification market estimates and forecasts, 2018 - 2030 (USD Million)
5.3.4. Total RNA Isolation & Purification
5.3.4.1. Total RNA isolation & purification market estimates and forecasts, 2018 - 2030 (USD Million)
5.3.5. Other
5.3.5.1. Other market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. Application Business Analysis
6.1. Nucleic Acid Isolation and Purification Market: Application Movement Analysis
6.2. Precision Medicine
6.2.1. Precision medicine market estimates and forecasts, 2018 - 2030 (USD Million)
6.3. Diagnostics
6.3.1. Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
6.4. Drug Discovery & Development
6.4.1. Drug discovery & development market estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Agriculture and Animal Research
6.5.1. Agriculture and animal research market estimates and forecasts, 2018 - 2030 (USD Million)
6.6. Other Applications
6.6.1. Other applications market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Method Business Analysis
7.1. Nucleic Acid Isolation and Purification Market: Method Movement Analysis
7.2. Column Based
7.2.1. Column based medicine market estimates and forecasts, 2018 - 2030 (USD Million)
7.3. Magnetic Beads
7.3.1. Magnetic beads market estimates and forecasts, 2018 - 2030 (USD Million)
7.4. Reagent Based
7.4.1. Reagent based market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8. End-use Business Analysis
8.1. Nucleic Acid Isolation and Purification Market: End-use Movement Analysis
8.2. Academic Research Institutes
8.2.1. Academic research institutes market estimates and forecasts, 2018 - 2030 (USD million)
8.3. Pharmaceutical and Biotechnology Companies
8.3.1. Pharmaceutical and biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
8.4. Contract Research Organizations
8.4.1. Contract research organizations market estimates and forecasts, 2018 - 2030 (USD Million)
8.5. Hospitals and Diagnostic Centers
8.5.1. Hospitals and diagnostic centers market estimates and forecasts, 2018 - 2030 (USD Million)
8.6. Other End-use
8.6.1. Other end-use market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 9. Regional Business Analysis
9.1. 4.1. Nucleic Acid Isolation and Purification Market: Regional Outlook
9.2. North America
9.2.1. North America market estimates and forecasts, 2018 - 2030 (USD Million)
9.2.2. U.S.
9.2.2.1. Key country dynamics
9.2.2.2. Competitive scenario
9.2.2.3. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
9.2.3. Canada
9.2.3.1. Key country dynamics
9.2.3.2. Competitive scenario
9.2.3.3. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
9.3. Europe
9.3.1. Europe market estimates and forecasts, 2018 - 2030 (USD Million)
9.3.2. UK
9.3.2.1. Key country dynamics
9.3.2.2. Competitive scenario
9.3.2.3. UK market estimates and forecasts, 2018 - 2030 (USD Million)
9.3.3. Germany
9.3.3.1. Key country dynamics
9.3.3.2. Competitive scenario
9.3.3.3. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
9.3.4. France
9.3.4.1. Key country dynamics
9.3.4.2. Competitive scenario
9.3.4.3. France market estimates and forecasts, 2018 - 2030 (USD Million)
9.3.5. Italy
9.3.5.1. Key country dynamics
9.3.5.2. Competitive scenario
9.3.5.3. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
9.3.6. Spain
9.3.6.1. Key country dynamics
9.3.6.2. Competitive scenario
9.3.6.3. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
9.3.7. Norway
9.3.7.1. Key country dynamics
9.3.7.2. Competitive scenario
9.3.7.3. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
9.3.8. Sweden
9.3.8.1. Key country dynamics
9.3.8.2. Competitive scenario
9.3.8.3. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
9.3.9. Denmark
9.3.9.1. Key country dynamics
9.3.9.2. Competitive scenario
9.3.9.3. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
9.4.2. Japan
9.4.2.1. Key country dynamics
9.4.2.2. Competitive scenario
9.4.2.3. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
9.4.3. China
9.4.3.1. Key country dynamics
9.4.3.2. Competitive scenario
9.4.3.3. China market estimates and forecasts, 2018 - 2030 (USD Million)
9.4.4. India
9.4.4.1. Key country dynamics
9.4.4.2. Competitive scenario
9.4.4.3. India market estimates and forecasts, 2018 - 2030 (USD Million)
9.4.5. Australia
9.4.5.1. Key country dynamics
9.4.5.2. Competitive scenario
9.4.5.3. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
9.4.6. South Korea
9.4.6.1. Key country dynamics
9.4.6.2. Competitive scenario
9.4.6.3. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
9.4.7. Thailand
9.4.7.1. Key country dynamics
9.4.7.2. Competitive scenario
9.4.7.3. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
9.5. Latin America
9.5.1. Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
9.5.2. Brazil
9.5.2.1. Key country dynamics
9.5.2.2. Competitive scenario
9.5.2.3. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
9.5.3. Mexico
9.5.3.1. Key country dynamics
9.5.3.2. Competitive scenario
9.5.3.3. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
9.5.4. Argentina
9.5.4.1. Key country dynamics
9.5.4.2. Competitive scenario
9.5.4.3. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
9.6. MEA
9.6.1. MEA market estimates and forecasts, 2018 - 2030 (USD Million)
9.6.2. South Africa
9.6.2.1. Key country dynamics
9.6.2.2. Competitive scenario
9.6.2.3. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
9.6.3. Saudi Arabia
9.6.3.1. Key country dynamics
9.6.3.2. Competitive scenario
9.6.3.3. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
9.6.4. UAE
9.6.4.1. Key country dynamics
9.6.4.2. Competitive scenario
9.6.4.3. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
9.6.5. Kuwait
9.6.5.1. Key country dynamics
9.6.5.2. Competitive scenario
9.6.5.3. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2023
10.4. Company Profiles/Listing
10.4.1. QIAGEN
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. Thermo Fisher Scientific, Inc.
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. Illumina, Inc.
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. Danaher
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. F. Hoffmann-La Roche Ltd
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Bio-synthesis
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. Merck KGaA
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
10.4.8. Agilent Technologies
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product benchmarking
10.4.8.4. Strategic initiatives
10.4.9. Bio-Rad Laboratories, Inc.
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product benchmarking
10.4.9.4. Strategic initiatives
10.4.10. Takara Bio Inc.
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product benchmarking
10.4.10.4. Strategic initiatives
10.4.11. Promega Corporation
10.4.11.1. Company overview
10.4.11.2. Financial performance
10.4.11.3. Product benchmarking
10.4.11.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America nucleic acid isolation and purification market, by country, 2018 - 2030 (USD Million)
Table 3 North America nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 4 North America nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 5 North America nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 6 North America nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 7 North America nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 8 U.S. nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 9 U.S. nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 10 U.S. nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 11 U.S. nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 12 U.S. nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 13 Canada nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 14 Canada nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 15 Canada nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 16 Canada nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 17 Canada nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 18 Europe nucleic acid isolation and purification market, by country, 2018 - 2030 (USD Million)
Table 19 Europe nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 20 Europe nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 21 Europe nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 22 Europe nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 23 Europe nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 24 Germany nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 25 Germany nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 26 Germany nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 27 Germany nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 28 Germany nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 29 UK nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 30 UK nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 31 UK nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 32 UK nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 33 UK nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 34 France nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 35 France nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 36 France nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 37 France nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 38 France nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 39 Italy nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 40 Italy nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 41 Italy nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 42 Italy nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 43 Italy nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 44 Spain nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 45 Spain nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 46 Spain nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 47 Spain nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 48 Spain nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 49 Denmark nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 50 Denmark nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 51 Denmark nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 52 Denmark nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 53 Denmark nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 54 Sweden nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 55 Sweden nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 56 Sweden nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 57 Sweden nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 58 Sweden nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 59 Norway nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 60 Norway nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 61 Norway nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 62 Norway nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 63 Norway nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 64 Asia Pacific nucleic acid isolation and purification market, by country, 2018 - 2030 (USD Million)
Table 65 Asia Pacific nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 66 Asia Pacific nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 67 Asia Pacific nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 68 Asia Pacific nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 69 Asia Pacific nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 70 China nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 71 China nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 72 China nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 73 China nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 74 China nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 75 Japan nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 76 Japan nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 77 Japan nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 78 Japan nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 79 Japan nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 80 India nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 81 India nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 82 India nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 83 India nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 84 India nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 85 South Korea nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 86 South Korea nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 87 South Korea nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 88 South Korea nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 89 South Korea nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 90 Australia nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 91 Australia nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 92 Australia nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 93 Australia nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 94 Australia nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 95 Thailand nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 96 Thailand nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 97 Thailand nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 98 Thailand nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 99 Thailand nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 100 Latin America nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 101 Latin America nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 102 Latin America nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 103 Latin America nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 104 Latin America nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 105 Brazil nucleic acid isolation and purification market, by product, 2018-2030 (USD Million)
Table 106 Brazil nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 107 Brazil nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 108 Brazil nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 109 Brazil nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 110 Mexico nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 111 Mexico nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 112 Mexico nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 113 Mexico nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 114 Mexico nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 115 Argentina nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 116 Argentina nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 117 Argentina nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 118 Argentina nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 119 Argentina nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 120 MEA nucleic acid isolation and purification market, by country, 2018 - 2030 (USD Million)
Table 121 MEA nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 122 MEA nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 123 MEA nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 124 MEA nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 125 MEA nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 126 South Africa nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 127 South Africa nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 128 South Africa nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 129 South Africa nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 130 South Africa nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 131 Saudi Arabia nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 132 Saudi Arabia nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 133 Saudi Arabia nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 134 Saudi Arabia nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 135 Saudi Arabia nucleic acid isolation and purification market, by end-use, 2018-2030 (USD Million)
Table 136 UAE nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 137 UAE nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 138 UAE nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 139 UAE nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 140 UAE nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
Table 141 Kuwait nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
Table 142 Kuwait nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
Table 143 Kuwait nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
Table 144 Kuwait nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
Table 145 Kuwait nucleic acid isolation and purification market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD product & servicing for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Parent market outlook
Fig. 9 Nucleic acid isolation and purification market driver impact
Fig. 10 Nucleic acid isolation and purification market restraint impact
Fig. 11 Nucleic acid isolation and purification market: Product outlook and key takeaways
Fig. 12 Nucleic acid isolation and purification market: Product movement analysis
Fig. 13 Kits & reagents market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 14 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 15 Manual market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 16 Automatic market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 Nucleic acid isolation and purification market: Type outlook and key takeaways
Fig. 18 Nucleic acid isolation and purification market: Type movement analysis
Fig. 19 DNA isolation & purification market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Genomic DNA isolation & purification market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Plasmid DNA isolation & purification market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Viral DNA isolation & purification market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Other market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 RNA isolation & purification market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 miRNA Isolation & Purification market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 mRNA isolation & purification market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Total RNA isolation & purification market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Other market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Nucleic acid isolation and purification market: Application outlook and key takeaways
Fig. 30 Nucleic acid isolation and purification market: Application movement analysis
Fig. 31 Precision medicine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Drug discovery & development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Agriculture and animal research market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Other applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Nucleic acid isolation and purification market: Method outlook and key takeaways
Fig. 37 Nucleic acid isolation and purification market: Method movement analysis
Fig. 38 Column based market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Magnetic beads market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Reagent based market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Others applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Nucleic acid isolation and purification market: End-use outlook and key takeaways
Fig. 43 Nucleic acid isolation and purification market: End-use movement Analysis
Fig. 44 Academic research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Pharmaceutical - biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Contract research organizations laboratories market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 47 Hospitals and diagnostic centers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Other end-use market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 49 Global nucleic acid isolation and purification market: Regional outlook and key takeaways
Fig. 50 Global nucleic acid isolation and purification market: Regional movement analysis
Fig. 51 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Market Segmentation
The incidence of genetic disorders, cancer, and infectious diseases is growing globally. Disorders such as thalassemia, sickle cell anemia, and cystic fibrosis are caused by genetic aberrations in an individual’s DNA. Studying nucleic acids helps gain insight into these diseases. The various types of cancers are of breast, skin, and lung, among others. In 2018, about 9.6 million people died due to cancer worldwide, as per WHO. About 70% of these deaths were reported in low- and middle-income countries. Cancer is the second leading cause of death. Apart from cancer, infectious diseases are also a major cause of concern. The diagnostic tests used for the detection of infectious diseases are generally unsatisfactory. Thus, nucleic acid-based diagnostics have become the most widely accepted clinical tests for infectious diseases worldwide. Biotech and pharmaceutical companies exhibit a growing demand for NAIP kits and systems. This can be attributed to the fact that the analysis of human DNA and RNA is now an integral part of the diagnosis, analysis, and prevention of genetic diseases across the globe.
There has been a significant increase in public-private funding for R&D pertaining to biotechnology. Research costs associated with the development of biotech products are significantly high, and they require highly skilled personnel. The growing collaborations between different companies and organizations in the biotech industry are a major example of a rise in interest in the field. For instance, The Agricultural Genetic Engineering Institute (AGERI) in Egypt has collaborated with Hi-Bred, a U.S.-based company, to develop novel strains of Bacillus Thuringiensis (BT) and use them for developing insect-resistant maize. In Indonesia, the U.S. Agency for International Development (USAID) has entered a collaboration with the Central Research Institute for Food Crops (CRIFC) & Syngenta, which is aimed at developing maize resistant to Asian corn borer. Thus, the industry is now witnessing a surge in public-private partnerships and funding in the fields of biotechnology and life sciences. This trend is expected to impel market growth.
DNA extraction is one of the basic steps in genomic research and studies and hence is performed in thousands of laboratories worldwide to serve various applications. The cost of instruments and methods required for DNA extraction is one of the major key elements to consider when choosing the best DNA extraction means for different applications. Although technological advancements to simplify DNA isolation protocol continue to take place, the high cost associated with technologies and assays is anticipated to limit their adoption under certain circumstances. This is mainly observed in countries with low budgets for genomic research. These countries are not able to utilize advanced DNA/RNA extraction tools due to their high cost, which affects the revenue generation for this market in emerging countries. Several reports on methods of nucleic acid isolation are time-consuming and expensive. Moreover, the high cost of reagents required for nucleic acid extraction is also inhibiting the adoption of these methods.
This section will provide insights into the contents included in this nucleic acid isolation and purification market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
Company overview
Financial performance
Product benchmarking
Latest strategic developments
Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance
A three-pronged approach was followed for deducing the nucleic acid isolation and purification market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:
Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for nucleic acid isolation and purification market to gather the most reliable and current information possible.
Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of nucleic acid isolation and purification market data depending on the type of information we’re trying to uncover in our research.
Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.
Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.
Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.
Qualitative Functional Deployment (QFD) Modelling for market share assessment.
Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.
Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.
Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.
This step also entails the finalization of the report scope and data representation pattern.
Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.
The nucleic acid isolation and purification market was categorized into six segments, namely product (Kits & Reagents, Instruments), type (DNA Isolation & Purification, RNA Isolation & Purification), method (Column Based, Magnetic Beads, Reagent Based), application (Precision Medicine, Diagnostics, Drug Discovery & Development, Agriculture and Animal Research), end-use (Academic Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Hospitals and Diagnostic Centers), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)
The nucleic acid isolation and purification market was segmented into product, type, method, application, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:
Demand estimation of each product across countries/regions summed up to from the total market.
Variable analysis for demand forecast.
Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.
Primary interviews for data revalidation and insight collection.
Used extensively for new product forecasting or analyzing penetration levels.
Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.
Primary interviews and vendor-based primary research for variable impact analysis.
The nucleic acid isolation and purification market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; Germany; the UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Mexico, Argentina; South Africa; Saudi Arabia, UAE; Kuwait.
All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.
The nucleic acid isolation and purification market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:
QIAGEN - QIAGEN is a biotechnology-based company, globally operating in over 20 countries. Key business areas of the company include assay technologies for molecular diagnostics, pharmaceutical, academic, and applied testing. The company’s product portfolio comprises a wide range of molecular testing applications. It markets over 500 products, including consumable kits and automation systems. Furthermore, molecular technologies developed by the company are being utilized by forensic technicians. The company is also involved in the isolation of genetic material from biological samples. Key customers include healthcare providers, pharmaceutical & biotechnology companies, government or industry customers, and researchers.
THERMO FISHER SCIENTIFIC, INC. - Thermo Fisher Scientific, Inc. is a developer, manufacturer, and provider of laboratory reagents, equipment, analytical instruments, & consumables. The company was formed by the merger of Fisher Scientific and Thermo Electron. It operates through brands such as Thermo Scientific, Applied Biosystems, Fisher Scientific, Invitrogen, and Unity Lab Services. The company’s analytical instrument segment provides equipment & instruments, consumables, as well as services, used in the production line, laboratory, and field applications. Its solutions segment provides instruments, reagents, and consumables used in disease diagnosis, medical & biological research, and novel drug & vaccines discovery.
ILLUMINA INC - Illumina, Inc. develops, manufactures, and commercializes integrated systems for the study of biological function and genetic variation. The company provides a range of products and services that serve genotyping, sequencing, and gene expression markets. It provides products to pharmaceutical companies, genomic research centers, clinical research organizations, academic institutions, and biotechnology companies. The company’s tools provide scientists the ability to perform genetic tests required for the extraction of medical information from advances in proteomics and genomics. The company has a strategic agreement with PerkinElmer, Inc. Verinata Health was formerly known as Artemis Health, Inc. and changed its name to Verinata Health, Inc. in April 2011.
DANAHER CORPORATION - Danaher designs, manufactures, and commercializes products as well as services catering to medical, professional, and commercial applications. The company operates through four segments: diagnostics, life sciences, environmental & applied solutions, and dental solutions. Danaher’s diagnostics segment offers reagents, analytical instruments, software, consumables, and services for physicians’ offices, hospitals, reference laboratories, and other critical care settings to diagnose various diseases. North America generated 38% of diagnostics share in 2016. Danaher’s facilities are in more than 60 countries across the world. In February 2011, the company acquired Beckman Coulter, Inc. to expand its business in molecular diagnostics.
F. HOFFMANN-LA ROCHE LTD. - F. Hoffmann-La Roche AG is involved in the development and manufacture of diagnostic & pharmaceutical products. It operates across two segments: pharmaceuticals and diagnostics. Roche sequencing (454 Life Sciences) is a subsidiary of Roche Diagnostics Corporation. In March 2007, Roche Diagnostics Corporation completed a successful purchase agreement with 454 Life Sciences, post which it has been a subsidiary of Roche. It is a privately held organization specializing in the development & commercialization of genomic sequencing & re-sequencing, metagenomics, RNA analysis, transcriptome sequencing, and DNA-targeted sequencing. The sequenced studies are used for applications in the fields of drug discovery, carcinoma studies, environmental ecology, immunogenetics, anthropology, agriculture, and paleontology. The products and systems developed by the company cater to various clients, such as drug makers, research institutes, clinical laboratories, and biotechnological companies.
AGILENT TECHNOLOGIES - Agilent Technologies is involved in providing analytical instruments & software for analytical scientists & clinical researchers. This company was formed in 1999 after it spun off Hewlett-Packard. It delivers products through direct sales, resellers, distributors, electronic commerce, and representatives of manufacturers. The company has offerings in pharmaceuticals, food, chemical & energy, environmental & forensics, and research segments. Its life sciences & applied market segments offer liquid & gas chromatography, mass spectrometry, spectroscopy, genomics & diagnostic consumables, services, and software. It has operations across the globe, including the Americas, Europe, Africa, and Asia Pacific. The company’s diagnostics and genomics business includes companion diagnostics, nucleic acid contract manufacturing & pathology, genomics, and reagent partnership businesses. Its genomics portfolio includes genotyping, DNA methylation profiling, identification of gene rearrangements, gene expression profiling, gene copy number determination, arrays for DNA mutation detection, NGS target enrichment, and genetic data management & interpretation support software.
BIO-RAD LABORATORIES, INC. - Bio-Rad Laboratories, Inc. provides tools & services for life science research, food science, and clinical diagnostics markets. The company has global operations. It offers solutions to propel scientific R&D and for the introduction of new technologies in proteomics, genomics, food safety, medical diagnostics, and drug discovery, among others. Bio-Rad’s business is segmented into life sciences and clinical diagnostics. Its life sciences segment develops, manufactures, and markets reagents, laboratory instruments, & apparatus used in clinical research, food testing regimes, & other applications. The company’s clinical diagnostics segment sells, manufactures, and supports test kits, test systems, specialized quality controls, & informatics systems that serve clinical laboratories in the diagnostics market. In April 2014, Bio-Rad Laboratories acquired GnuBio to expand its digital biology center.
TAKARA BIO, INC. - Takara Bio, Inc. is a global biotechnology company. It is the first company to commercialize PCR technology in Japan. The company also developed a RetroNectin reagent that is used as a global standard in gene therapy products. The company provides reagents and equipment as well as is engaged in the field of agricultural biotechnology, cell therapy, and gene therapy. The company was established as the biomedical business division of Takara Holdings, Inc., formerly known as Takara Shuzo Co., Ltd. The company has several number of distributors across the world.
PROMEGA CORPORATION - Promega Corporation is a global biotechnology manufacturer providing solutions for cell analysis, energy metabolism, PCR, biologics, protein-enzymes, genetics DNA markers, and analysis. Its portfolio consists of more than 4,000 products, with technical and bioinformatics support. It operates in more than 16 countries and has distribution facilities in 100 countries. Promega holds several patents in drug discovery, cellular analysis, cell biology, and bioluminescence.
Supply Side Estimates
Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.
Segment revenue determination via variable analysis and penetration modeling.
Competitive benchmarking to identify market leaders and their collective revenue shares.
Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.
Demand side estimates
Identifying parent markets and ancillary markets
Segment penetration analysis to obtain pertinent
revenue/volume
Heuristic forecasting with the help of subject matter experts
Forecasting via variable analysis
Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.
Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.
Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.
The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.
The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.
We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.
All market estimates and forecasts have been validated through primary interviews with the key industry participants.
Inflation has not been accounted for to estimate and forecast the market.
Numbers may not add up due to rounding off.
Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).
Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).
Latin America includes Central American countries and the South American continent
Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.
GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.
We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:
Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.
Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.
The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."